Found: 5
Select item for more details and to access through your institution.
Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 2, p. 465, doi. 10.1093/jac/dkr490
- By:
- Publication type:
- Article
Randomized, placebo-controlled, double blind, single- and multiple-dose study to evaluate the pharmacokinetics, safety and tolerability of avagacestat (BMS-708163) in healthy young male and elderly male and female Chinese subjects
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid‐dependent, human immunodeficiency virus seronegative participants.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 8, p. 1771, doi. 10.1111/bcp.13964
- By:
- Publication type:
- Article
The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 9, p. 661, doi. 10.1007/s40261-014-0219-9
- By:
- Publication type:
- Article
Antiviral Activity, Safety, and Exposure–Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002).
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 3, p. 442, doi. 10.1093/cid/cix239
- By:
- Publication type:
- Article